1. Observation on the systemic administration of autologous lymphokine activated killer cells and recombinant interleukin-2 to patients with cancer;Rosenberg;N Engl J Med,1985
2. Recent advances in the understanding of biochemistry and clinical pharmacology of interleukin-2;Fletcher;Lymphokine Res,1987
3. In vivo administration of purified human IL-2. II. Half life, immunologic effects and expansion of peripheral lymphoid cells in vivo with recombinant interleukin-2;Lotze;J Immunol,1985
4. Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin-2;Rosenstein;J Immunol,1986
5. Effects of interleukin-2 immunotherapy on renal function;Kozeny;J Clin Oncol,1988